Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: In vitro experiments and clinical application

Tetsuzo Tagawa, Ichiro Yoshino, Masafumi Yamaguchi, Atsushi Osoegawa, Toshifumi Kameyama, Seiichi Fukuyama, Takuro Kometani, Yoshihiko Maehara

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose. We studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor. Methods. In the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5∈min. After 48∈h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy. Results. The hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1-5∈min exposure to 10∈μg/ml of hypotonic cisplatin inhibited growth by more than 80%. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16-36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery. Conclusion. Hypotonic cisplatin treatment is effective against MPM, and should be investigated further.

Original languageEnglish
Pages (from-to)135-139
Number of pages5
JournalSurgery today
Volume36
Issue number2
DOIs
Publication statusPublished - Feb 1 2006

Fingerprint

Cisplatin
Pneumonectomy
Therapeutics
Growth
Cell Line
Malignant Mesothelioma
In Vitro Techniques
Mesothelioma
Sodium Chloride
Neoplasm Metastasis
Recurrence
Lung
Water
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma : In vitro experiments and clinical application. / Tagawa, Tetsuzo; Yoshino, Ichiro; Yamaguchi, Masafumi; Osoegawa, Atsushi; Kameyama, Toshifumi; Fukuyama, Seiichi; Kometani, Takuro; Maehara, Yoshihiko.

In: Surgery today, Vol. 36, No. 2, 01.02.2006, p. 135-139.

Research output: Contribution to journalArticle

Tagawa, Tetsuzo ; Yoshino, Ichiro ; Yamaguchi, Masafumi ; Osoegawa, Atsushi ; Kameyama, Toshifumi ; Fukuyama, Seiichi ; Kometani, Takuro ; Maehara, Yoshihiko. / Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma : In vitro experiments and clinical application. In: Surgery today. 2006 ; Vol. 36, No. 2. pp. 135-139.
@article{4dff64c0a9e74c12a2080a7d40d28782,
title = "Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: In vitro experiments and clinical application",
abstract = "Purpose. We studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor. Methods. In the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5∈min. After 48∈h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy. Results. The hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1-5∈min exposure to 10∈μg/ml of hypotonic cisplatin inhibited growth by more than 80{\%}. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16-36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery. Conclusion. Hypotonic cisplatin treatment is effective against MPM, and should be investigated further.",
author = "Tetsuzo Tagawa and Ichiro Yoshino and Masafumi Yamaguchi and Atsushi Osoegawa and Toshifumi Kameyama and Seiichi Fukuyama and Takuro Kometani and Yoshihiko Maehara",
year = "2006",
month = "2",
day = "1",
doi = "10.1007/s00595-005-3132-2",
language = "English",
volume = "36",
pages = "135--139",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma

T2 - In vitro experiments and clinical application

AU - Tagawa, Tetsuzo

AU - Yoshino, Ichiro

AU - Yamaguchi, Masafumi

AU - Osoegawa, Atsushi

AU - Kameyama, Toshifumi

AU - Fukuyama, Seiichi

AU - Kometani, Takuro

AU - Maehara, Yoshihiko

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Purpose. We studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor. Methods. In the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5∈min. After 48∈h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy. Results. The hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1-5∈min exposure to 10∈μg/ml of hypotonic cisplatin inhibited growth by more than 80%. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16-36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery. Conclusion. Hypotonic cisplatin treatment is effective against MPM, and should be investigated further.

AB - Purpose. We studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor. Methods. In the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5∈min. After 48∈h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy. Results. The hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1-5∈min exposure to 10∈μg/ml of hypotonic cisplatin inhibited growth by more than 80%. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16-36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery. Conclusion. Hypotonic cisplatin treatment is effective against MPM, and should be investigated further.

UR - http://www.scopus.com/inward/record.url?scp=31544442462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544442462&partnerID=8YFLogxK

U2 - 10.1007/s00595-005-3132-2

DO - 10.1007/s00595-005-3132-2

M3 - Article

C2 - 16440159

AN - SCOPUS:31544442462

VL - 36

SP - 135

EP - 139

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 2

ER -